Craig Hettenbach

Stock Analyst at Morgan Stanley

(2.67)
# 2,152
Out of 5,001 analysts
301
Total ratings
57.04%
Success rate
-0.58%
Average return

Stocks Rated by Craig Hettenbach

Hinge Health
Sep 23, 2025
Maintains: Overweight
Price Target: $57$67
Current: $49.08
Upside: +36.51%
Veeva Systems
Aug 28, 2025
Maintains: Underweight
Price Target: $210$222
Current: $297.91
Upside: -25.48%
Silicon Laboratories
Aug 6, 2025
Maintains: Equal-Weight
Price Target: $157$144
Current: $131.12
Upside: +9.82%
HCA Healthcare
Jul 28, 2025
Maintains: Equal-Weight
Price Target: $410$400
Current: $426.20
Upside: -6.15%
Omada Health
Jul 1, 2025
Initiates: Overweight
Price Target: $25
Current: $22.11
Upside: +13.07%
Hims & Hers Health
Jun 11, 2025
Reiterates: Equal-Weight
Price Target: $40
Current: $56.72
Upside: -29.48%
Tenet Healthcare
Jun 9, 2025
Maintains: Overweight
Price Target: $175$210
Current: $203.04
Upside: +3.43%
Universal Health Services
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $204.44
Upside: -2.17%
Ardent Health
Jan 21, 2025
Maintains: Overweight
Price Target: $24$22
Current: $13.25
Upside: +66.04%
American Well
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $20$11
Current: $6.15
Upside: +70.73%
Maintains: Equal-Weight
Price Target: $7$6
Current: $4.23
Upside: +41.84%
Maintains: Equal-Weight
Price Target: $9$5
Current: $4.06
Upside: +23.15%
Maintains: Equal-Weight
Price Target: $96$114
Current: $76.98
Upside: +48.09%
Maintains: Overweight
Price Target: $62$57
Current: $30.55
Upside: +86.58%
Maintains: Overweight
Price Target: $85$81
Current: $64.22
Upside: +26.13%
Maintains: Equal-Weight
Price Target: $55$35
Current: $73.15
Upside: -52.15%
Maintains: Overweight
Price Target: $20$18
Current: $18.93
Upside: -4.91%
Maintains: Overweight
Price Target: $208$185
Current: $91.08
Upside: +103.12%
Maintains: Equal-Weight
Price Target: $162$167
Current: $219.53
Upside: -23.93%
Maintains: Equal-Weight
Price Target: $42$42
Current: $123.75
Upside: -66.06%
Maintains: Equal-Weight
Price Target: $165$159
Current: $190.58
Upside: -16.57%
Maintains: Overweight
Price Target: $115$125
Current: $75.39
Upside: +65.80%
Maintains: Overweight
Price Target: $57$72
Current: $329.91
Upside: -78.08%
Maintains: Underweight
Price Target: $193$195
Current: $183.73
Upside: +6.13%
Maintains: Overweight
Price Target: $515$488
Current: $345.30
Upside: +41.33%
Maintains: Overweight
Price Target: $297$296
Current: $191.36
Upside: +54.68%
Maintains: Overweight
Price Target: $273$368
Current: $287.06
Upside: +28.20%
Maintains: Overweight
Price Target: $500$513
Current: $260.17
Upside: +97.18%
Maintains: Overweight
Price Target: $321$275
Current: $288.25
Upside: -4.60%
Maintains: Overweight
Price Target: $94$88
Current: $35.68
Upside: +146.64%
Upgrades: Equal-Weight
Price Target: n/a
Current: $49.31
Upside: -
Maintains: Overweight
Price Target: $173$185
Current: $68.34
Upside: +170.71%
Downgrades: Equal-Weight
Price Target: $190$213
Current: $227.73
Upside: -6.47%
Maintains: Equal-Weight
Price Target: $53$58
Current: $180.75
Upside: -67.91%
Maintains: Equal-Weight
Price Target: $101$117
Current: $245.70
Upside: -52.38%